Clinical Trial Update: Detecting Infections Rapidly and Easily for Candidemia Trial - Part 2 (direcT2 Study)

View source ↗

Summary

This is a completed clinical trial update for the direcT2 study evaluating rapid detection of candidemia by T2 Biosystems. The sponsor listed is T2 Biosystems.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Candidemia

Snippet

Sponsor: T2 Biosystems | Conditions: Candidemia | Status: COMPLETED